CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in FATE — Fate Therapeutics Inc
CIK 884546
SAN FRANCISCO, CA
Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$907,527
+$138,592 QoQ
Shares Held
756,273
-3.6% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. FATE ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $907,527 | 756,273 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $768,935 | 784,628 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $990,260 | 785,921 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $821,980 | 733,911 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $556,021 | 703,825 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,270,962 | 770,280 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,673,328 | 763,808 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,884,350 | 879,375 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,019,469 | 956,331 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,676,491 | 983,019 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,879,835 | 886,715 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,031,087 | 636,783 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,527,359 | 618,835 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,201,646 | 614,633 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,479,121 | 601,478 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,368,738 | 821,983 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $31,612,360 | 815,382 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $46,498,365 | 794,708 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $46,072,171 | 777,327 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $50,610,547 | 583,138 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $46,529,997 | 564,342 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $43,685,318 | 480,428 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $18,949,257 | 474,087 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $15,242,972 | 444,272 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $8,559,867 | 385,406 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||